Medical Properties Trust Inc [MPW] stock is trading at $4.03, up 3.07%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MPW shares have gain 1.00% over the last week, with a monthly amount drifted -1.95%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medical Properties Trust Inc [NYSE: MPW] stock has seen the most recent analyst activity on September 13, 2024, when Colliers Securities upgraded its rating to a Buy but kept the price target unchanged to $6.50 for it. Previously, Exane BNP Paribas downgraded its rating to Neutral on July 02, 2024, and kept the price target unchanged to $4. On April 17, 2024, upgrade upgraded it’s rating to Hold but maintained its price target of $5 on the stock. Colliers Securities downgraded its rating to a Neutral and decreased its price target to $4.25 on April 10, 2024. Exane BNP Paribas upgraded its rating to a Outperform but $6 remained the price target by the analyst firm on March 01, 2024. Deutsche Bank started tracking with a Sell rating for this stock on January 30, 2024, and assigned it a price target of $2. In a note dated January 05, 2024, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
Medical Properties Trust Inc [MPW] stock has fluctuated between $2.92 and $6.55 over the past year. Currently, Wall Street analysts expect the stock to reach $6.75 within the next 12 months. Medical Properties Trust Inc [NYSE: MPW] shares were valued at $4.03 at the most recent close of the market. An investor can expect a potential return of 67.49% based on the average MPW price forecast.
Analyzing the MPW fundamentals
Medical Properties Trust Inc [NYSE:MPW] reported sales of 641.32M for the trailing twelve months, which represents a drop of -26.34%. Gross Profit Margin for this corporation currently stands at -0.11% with Operating Profit Margin at -0.44%, Pretax Profit Margin comes in at -3.87%, and Net Profit Margin reading is -3.93%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.39 and Total Capital is -0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.92 points at the first support level, and at 3.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.13, and for the 2nd resistance point, it is at 4.24.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 3.77, the price to book ratio is 0.44.
Transactions by insiders
Recent insider trading involved Hanna James Kevin, Senior VP, Controller & CAO, that happened on Dec 26 ’24 when 11641.0 shares were sold. SVP of Operations, Hooper Rosa Handley completed a deal on Dec 23 ’24 to sell 3000.0 shares. Meanwhile, Officer Hanna James Kevin bought 11641.0 shares on Dec 26 ’24.
